Delivering co-stimulatory tumor necrosis factor receptor agonism for cancer immunotherapy: past, current and future perspectives.

Dadas, Osman; Ertay, Ayse; Cragg, Mark S

Dadas, Osman; Ertay, Ayse; Cragg, Mark S.

Afiliación

Dadas O; Antibody and Vaccine Group, School of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
Ertay A; School of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
Cragg MS; Antibody and Vaccine Group, School of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.

Front Immunol ; 14: 1147467, 2023.

Article en En | MEDLINE | ID: mdl-37180119

Asunto(s)

Neoplasias; Humanos; Receptores del Factor de Necrosis Tumoral; Factor de Necrosis Tumoral alfa; Sistema Inmunológico/patología; Inmunoterapia

Palabras clave

TNFR; agonism; cancer; co-stimulation; immunotherapy

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Límite: Humans Idioma: En Revista: Front Immunol Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google